C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2526217
Heteroaryl-fused pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
L'invention concerne des composés de pyrimidinyle accolés à un hétéroaryle, des sels acceptables d'un point de vue pharmaceutique et des promédicaments de ceux-ci, et des compositions contenant un excipient acceptable d'un point de vue pharmaceutique et un ou plusieurs composés de pyrimidinyle accolés à un hétéroaryle, seuls ou combinés à au moins un agent thérapeutique supplémentaire. L'invention concerne également des méthodes d'utilisation desdits composés de pyrimidinyle accolés à un hétéroaryle, seuls ou combinés à au moins un agent thérapeutique, dans la prophylaxie ou le traitement des maladies prolifératives.
Burger Matthew T.
Constantine Ryan N.
Lagniton Liana M.
Wang Weibo
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Heteroaryl-fused pyrimidinyl compounds as anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl-fused pyrimidinyl compounds as anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl-fused pyrimidinyl compounds as anticancer agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1672036